Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine

Abstract Purpose The study was designed to elucidate the predictive value of the number of lymph node metastases (LNMs) and lymph node ratio (LNR) for response to therapy restratification system (RTRS). Methods From December 2015 to December 2019, 1228 patients who accepted radioactive iodine (RAI)...

Full description

Bibliographic Details
Main Authors: Canhua Yun, Juan Xiao, Jingjia Cao, Chunchun Shao, Lihua Wang, Wei Zhang, Hongying Jia
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.4288
_version_ 1819118292950843392
author Canhua Yun
Juan Xiao
Jingjia Cao
Chunchun Shao
Lihua Wang
Wei Zhang
Hongying Jia
author_facet Canhua Yun
Juan Xiao
Jingjia Cao
Chunchun Shao
Lihua Wang
Wei Zhang
Hongying Jia
author_sort Canhua Yun
collection DOAJ
description Abstract Purpose The study was designed to elucidate the predictive value of the number of lymph node metastases (LNMs) and lymph node ratio (LNR) for response to therapy restratification system (RTRS). Methods From December 2015 to December 2019, 1228 patients who accepted radioactive iodine (RAI) were collected in the study. After 6–8 months, response to RAI was evaluated as complete response (excellent response) and incomplete response (indeterminate, biochemical, and structural incomplete response). The study developed classification tree to determine the optimum LNMs and LNR that predicted response to RAI. Multivariate logistic regression analyses were further analyzed to find independent factors of response to RAI. Result The mean age of patients was 44 ± 12 and 71.09% (873/1228) were females. The best cutoff value of LNMs to affect RAI treatment response determined by classification tree was 5. Further in 388 patients with LNMs >5, the best cutoff value of LNR to affect RAI treatment response determined by classification tree was 0.30. With multivariate analysis, the study found that LNMs (>5), gender, lymph node dissection, and American Thyroid Association (ATA) risk classification were independent predictors of response to RAI for all 1228 patients; and LNR (>0.30), gender, and ATA risk classification for 388 patients with LNMs >5. The sensitivity analysis indicated that whether patients with LNM or not were included, the multivariate logistic regression model was kept stable. On subgroup analysis, no significant interactions were observed between the effect of LNMs/LNR and gender, N stage, ATA risk classification, lymph node dissection, or T stage. Conclusions With classification tree, the study found that LNMs and LNR could predict initial response to RAI, and their optimal cutoff values were 5 and 0.30, separately.
first_indexed 2024-12-22T05:46:34Z
format Article
id doaj.art-eca9931432c240aa9289dbef34d01e93
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-12-22T05:46:34Z
publishDate 2021-11-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-eca9931432c240aa9289dbef34d01e932022-12-21T18:37:01ZengWileyCancer Medicine2045-76342021-11-0110217610761910.1002/cam4.4288Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodineCanhua Yun0Juan Xiao1Jingjia Cao2Chunchun Shao3Lihua Wang4Wei Zhang5Hongying Jia6Department of Nuclear Medicine The Second HospitalCheeloo College of MedicineShandong University Jinan ChinaCenter of Evidence‐Based Medicine The Second HospitalCheeloo College of MedicineInstitute of Medical SciencesShandong University Jinan ChinaDepartment of Nuclear Medicine The Second HospitalCheeloo College of MedicineShandong University Jinan ChinaCenter of Evidence‐Based Medicine The Second HospitalCheeloo College of MedicineInstitute of Medical SciencesShandong University Jinan ChinaSchool of Public Health Cheeloo College of MedicineShandong University Jinan ChinaDepartment of Nuclear Medicine The Second HospitalCheeloo College of MedicineShandong University Jinan ChinaCenter of Evidence‐Based Medicine The Second HospitalCheeloo College of MedicineInstitute of Medical SciencesShandong University Jinan ChinaAbstract Purpose The study was designed to elucidate the predictive value of the number of lymph node metastases (LNMs) and lymph node ratio (LNR) for response to therapy restratification system (RTRS). Methods From December 2015 to December 2019, 1228 patients who accepted radioactive iodine (RAI) were collected in the study. After 6–8 months, response to RAI was evaluated as complete response (excellent response) and incomplete response (indeterminate, biochemical, and structural incomplete response). The study developed classification tree to determine the optimum LNMs and LNR that predicted response to RAI. Multivariate logistic regression analyses were further analyzed to find independent factors of response to RAI. Result The mean age of patients was 44 ± 12 and 71.09% (873/1228) were females. The best cutoff value of LNMs to affect RAI treatment response determined by classification tree was 5. Further in 388 patients with LNMs >5, the best cutoff value of LNR to affect RAI treatment response determined by classification tree was 0.30. With multivariate analysis, the study found that LNMs (>5), gender, lymph node dissection, and American Thyroid Association (ATA) risk classification were independent predictors of response to RAI for all 1228 patients; and LNR (>0.30), gender, and ATA risk classification for 388 patients with LNMs >5. The sensitivity analysis indicated that whether patients with LNM or not were included, the multivariate logistic regression model was kept stable. On subgroup analysis, no significant interactions were observed between the effect of LNMs/LNR and gender, N stage, ATA risk classification, lymph node dissection, or T stage. Conclusions With classification tree, the study found that LNMs and LNR could predict initial response to RAI, and their optimal cutoff values were 5 and 0.30, separately.https://doi.org/10.1002/cam4.4288classification treedifferentiated thyroid cancerLNMsLNRradioactive iodine
spellingShingle Canhua Yun
Juan Xiao
Jingjia Cao
Chunchun Shao
Lihua Wang
Wei Zhang
Hongying Jia
Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine
Cancer Medicine
classification tree
differentiated thyroid cancer
LNMs
LNR
radioactive iodine
title Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine
title_full Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine
title_fullStr Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine
title_full_unstemmed Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine
title_short Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine
title_sort lymph node metastases 5 and metastatic lymph node ratio 0 30 of differentiated thyroid cancer predict response to radioactive iodine
topic classification tree
differentiated thyroid cancer
LNMs
LNR
radioactive iodine
url https://doi.org/10.1002/cam4.4288
work_keys_str_mv AT canhuayun lymphnodemetastases5andmetastaticlymphnoderatio030ofdifferentiatedthyroidcancerpredictresponsetoradioactiveiodine
AT juanxiao lymphnodemetastases5andmetastaticlymphnoderatio030ofdifferentiatedthyroidcancerpredictresponsetoradioactiveiodine
AT jingjiacao lymphnodemetastases5andmetastaticlymphnoderatio030ofdifferentiatedthyroidcancerpredictresponsetoradioactiveiodine
AT chunchunshao lymphnodemetastases5andmetastaticlymphnoderatio030ofdifferentiatedthyroidcancerpredictresponsetoradioactiveiodine
AT lihuawang lymphnodemetastases5andmetastaticlymphnoderatio030ofdifferentiatedthyroidcancerpredictresponsetoradioactiveiodine
AT weizhang lymphnodemetastases5andmetastaticlymphnoderatio030ofdifferentiatedthyroidcancerpredictresponsetoradioactiveiodine
AT hongyingjia lymphnodemetastases5andmetastaticlymphnoderatio030ofdifferentiatedthyroidcancerpredictresponsetoradioactiveiodine